Valuation : Proteome Sciences plc

Market Cap 4.91M 6.64M 5.72M 5.42M 9.21M 634M 9.26M 64.34M 24.74M 323M 24.94M 24.39M 1.02B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.9M 26.91M 23.19M 21.95M 37.33M 2.57B 37.52M 261M 100M 1.31B 101M 98.85M 4.13B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
Current month-9.68%
1 month-21.13%
3 months-9.68%
6 months-17.65%
Current year-44.00%
1 week 1.2
Extreme 1.2
1.6
1 month 1.2
Extreme 1.2
2.1
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
7.5
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
13.75
Manager TitleAgeSince
Corporate Officer/Principal - 2017-03-31
Corporate Secretary - 2017-07-31
Director TitleAgeSince
Chairman 73 2014-06-29
Director/Board Member 62 2009-12-31
Director/Board Member 71 2014-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-57.70%-75.86% 6.64M
-1.36%-5.89%-23.14%-0.49% 176B
-0.72%-3.41%-3.49%+11.74% 116B
+0.19%-2.83%+6.20%+80.93% 61.36B
-1.92%-6.01%+8.80%+41.11% 49.42B
+0.81%-3.73%-6.67%-33.43% 48.44B
-1.75%-5.54%+9.25%-22.61% 31.33B
+0.43%-11.10% - - 28.56B
+0.58%+1.84%+31.28%-12.82% 24.37B
+0.49%-7.65%-12.44%+4.86% 21.57B
Average -0.33%-4.57%-5.32%-0.73% 55.78B
Weighted average by Cap. -0.69%-4.90%-6.07%+10.85%

Financials

2024 2025
Net sales 4.89M 6.61M 5.69M 5.39M 9.17M 631M 9.21M 64.04M 24.62M 321M 24.82M 24.28M 1.02B 3.76M 5.08M 4.38M 4.14M 7.05M 485M 7.08M 49.22M 18.93M 247M 19.08M 18.66M 780M
Net income -3.41M -4.61M -3.97M -3.76M -6.39M -440M -6.42M -44.63M -17.16M -224M -17.3M -16.92M -707M -3.06M -4.14M -3.57M -3.38M -5.74M -395M -5.77M -40.11M -15.42M -201M -15.55M -15.21M -636M
Net Debt 13.39M 18.11M 15.61M 14.78M 25.13M 1.73B 25.26M 176M 67.49M 880M 68.03M 66.53M 2.78B 14.99M 20.27M 17.46M 16.54M 28.12M 1.94B 28.26M 196M 75.53M 985M 76.13M 74.46M 3.11B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
26-09-11 GBX 1.400 0.00% 33,588
26-09-10 GBX 1.400 0.00% 726
26-09-09 GBX 1.400 0.00% 232
26-09-08 GBX 1.400 0.00% 2,633
26-09-07 GBX 1.400 0.00% 4,629
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!